Trevi Therapeutics (TRVI) Shareholder's Equity Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.16% |
| Dec 31, 2025 | 19.47% |
| Sep 30, 2025 | 19.97% |
| Jun 30, 2025 | 48.58% |
| Mar 31, 2025 | 111.83% |
| Dec 31, 2024 | 80.04% |
| Sep 30, 2024 | 73.05% |
| Jun 30, 2024 | 55.10% |
| Mar 31, 2024 | 45.09% |
| Dec 31, 2023 | 44.64% |
| Sep 30, 2023 | 36.01% |
| Jun 30, 2023 | 33.41% |
| Mar 31, 2023 | 29.54% |
| Dec 31, 2022 | 25.36% |
| Sep 30, 2022 | 21.88% |
| Jun 30, 2022 | -3.67% |
| Mar 31, 2022 | 27.87% |
| Dec 31, 2021 | 29.19% |
| Sep 30, 2021 | 28.29% |
| Jun 30, 2021 | 29.78% |
| Mar 31, 2021 | 31.32% |